The Story of Influenza Antivirals: Part 25

The media pressure pays off

Throughout the period from 2009 to 2014, the media reported on our efforts to obtain regulatory data and respond to Hayashi’s comment. To begin with, the BMJ and Channel 4 were our principal supporters, and then the rest of the media slowly got hold of the story and amplified our requests.

However, perhaps the most effective media asset was the Tamiflu p…